Osteoporosis pharmacotherapy following bone densitometry: Importance of patient beliefs and understanding of DXA results

Osteoporosis International

Volumn 22, Issue 5, 2011, Pages 1493-1501

  Brask Lindemann, D ^a   Cadarette, S M ^b   Eskildsen, P ^a   Abrahamsen, B ^c,d  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF TORONTO   (Canada)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

Bone density; Communication; DXA scanning; Osteoporosis; Self report

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID;

ADULT; AGE DISTRIBUTION; ARTICLE; BONE DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENERAL PRACTITIONER; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OSTEOPENIA; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT REFERRAL; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 79955477396     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1365-4     Document Type: Article

References (37)

1. A Cooper 2006 Compliance with treatment for osteoporosis Lancet 368 1648 17098078 10.1016/S0140-6736(06)69691-8 (Pubitemid 46055219)
2. JA Cramer S Silverman 2006 Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem Am J Med 119 S12 S17 16563936 10.1016/j.amjmed.2005.12.018
3. J Payer Z Killinger S Ivana P Celec 2007 Therapeutic adherence to bisphosphonates Biomed Pharmacother 61 191 193 17412550 10.1016/j.biopha.2007. 02.003 1:CAS:528:DC%2BD2sXlt1anu78%3D (Pubitemid 46686981)
4. V Rabenda R Mertens V Fabri, et al. 2008 Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women Osteoporos Int 19 6 811 818 17999022 10.1007/s00198-007-0506-x 1:CAS:528:DC%2BD1cXltFyjurs%3D
5. ES Siris PL Selby KG Saag F Borgstrom RM Herings SL Silverman 2009 Impact of osteoporosis treatment adherence on fracture rates in North America and Europe Am J Med 122 S3 S13 19187810 10.1016/j.amjmed.2008.12.002
6. P Kothawala E Badamgarav S Ryu RM Miller RJ Halbert 2007 Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Mayo Clin Proc 82 1493 1501 18053457 10.4065/82.12.1493 (Pubitemid 350211697)
7. JA Cramer DT Gold SL Silverman EM Lewiecki 2007 A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 1023 1031 17308956 10.1007/s00198-006-0322-8 1:CAS:528:DC%2BD2sXntVOlsrY%3D (Pubitemid 47019996)
8. DT Gold IM Alexander MP Ettinger 2006 How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy Ann Pharmacother 40 1143 1150 16735667 10.1345/aph.1G534 1:CAS:528: DC%2BD28XmsFyqt7w%3D (Pubitemid 43886973)
9. PK Moller 2003 Pricing and reimbursement of drugs in Denmark Eur J Health Econ 4 60 65 10.1007/s10198-003-0165-6 (Pubitemid 36457058)
10. P Vestergaard L Rejnmark L Mosekilde 2005 Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark Osteoporos Int 16 134 141 15197546 10.1007/s00198-004-1680-8 (Pubitemid 40193199)
11. SB Jaglal C Cameron GA Hawker, et al. 2006 Development of an integrated-care delivery model for post-fracture care in Ontario, Canada Osteoporos Int 17 1337 1345 16821001 10.1007/s00198-006-0076-3 1:STN:280:DC%2BD28vktFOrsg%3D%3D (Pubitemid 44127320)
12. B Haussler H Gothe D Gol G Glaeske L Pientka D Felsenberg 2007 Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study Osteoporos Int 18 77 84 17048064 10.1007/s00198-006-0206-y 1:STN:280: DC%2BD2s%2FivVCksQ%3D%3D (Pubitemid 44885498)
13. F Lekkerkerker JA Kanis N Alsayed, et al. 2007 Adherence to treatment of osteoporosis: a need for study Osteoporos Int 18 1311 1317 17585359 10.1007/s00198-007-0410-4 1:STN:280:DC%2BD2srjtVensw%3D%3D (Pubitemid 47389473)
14. SM Cadarette DE Beaton MA Gignac SB Jaglal L Dickson GA Hawker 2007 Minimal error in self-report of having had DXA, but self-report of its results was poor J Clin Epidemiol 60 1306 1311 17998086 10.1016/j.jclinepi.2007.02.010 (Pubitemid 350064598)
15. CS Pickney JA Arnason 2005 Correlation between patient recall of bone densitometry results and subsequent treatment adherence Osteoporos Int 16 1156 1160 15744452 10.1007/s00198-004-1818-8 (Pubitemid 41225103)
16. NS Fitt SL Mitchell A Cranney K Gulenchyn M Huang P Tugwell 2001 Influence of bone densitometry results on the treatment of osteoporosis CMAJ 164 777 781 11276543 1:STN:280:DC%2BD3M7os1Smsg%3D%3D (Pubitemid 32511037)
17. SM Cadarette MA Gignac SB Jaglal DE Beaton GA Hawker 2007 Access to osteoporosis treatment is critically linked to access to dual-energy X-ray absorptiometry testing Med Care 45 896 901 17712261 10.1097/MLR.0b013e318054689f
18. Lægemiddelstyrelsen (2003) Kriterier for enkelttilskud til Ebixa, kolinesterasehæmmere, osteoporosemidler, Plavix og Persantin. Ugeskr Læger;2845
19. WHO Study Group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group World Health Organ Tech Rep Ser 843 1 129
20. SM Cadarette MA Gignac SB Jaglal DE Beaton GA Hawker 2009 Measuring patient perceptions about osteoporosis pharmacotherapy BMC Res Notes 2 133 19602268 10.1186/1756-0500-2-133
21. T Byrt 1996 How good is that agreement? Epidemiology 7 561 8862998 1:STN:280:DyaK2s%2Fhs1elsQ%3D%3D
22. A Pressman B Forsyth B Ettinger AN Tosteson 2001 Initiation of osteoporosis treatment after bone mineral density testing Osteoporos Int 12 337 342 11444079 10.1007/s001980170099 1:STN:280:DC%2BD3MzovF2hsA%3D%3D (Pubitemid 32606455)
23. AN Tosteson MR Grove CS Hammond, et al. 2003 Early discontinuation of treatment for osteoporosis Am J Med 115 209 216 12947959 10.1016/S0002-9343(03) 00362-0 (Pubitemid 37338146)
24. ES Siris ST Harris CJ Rosen, et al. 2006 Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 1013 1022 16901023 10.4065/81.8.1013 (Pubitemid 44175011)
25. R Kilding R Eastell N Peel 2002 Do patients receive appropriate information and treatment following bone mineral density measurements? Rheumatol (Oxf) 41 1073 1074 10.1093/rheumatology/41.9.1073 1:STN:280: DC%2BD38vlsVKntQ%3D%3D
26. TW Weiss ES Siris E Barrett-Connor PD Miller CA McHorney 2007 Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study Osteoporos Int 18 11 1473 1480 17577594 10.1007/s00198-007-0408-y 1:STN:280:DC%2BD2srosVGhtQ%3D%3D (Pubitemid 47515370)
27. R Chenot C Scheidt-Nave S Gabler MM Kochen W Himmel 2007 German primary care doctors' awareness of osteoporosis and knowledge of national guidelines Exp Clin Endocrinol Diabetes 115 584 589 17943692 10.1055/s-2007-981454 1:CAS:528:DC%2BD2sXhtleku7fN (Pubitemid 350070928)
28. SB Jaglal J Carroll G Hawker, et al. 2003 How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs Can Fam Physician 49 462 468 12729242 (Pubitemid 36700652)
29. MK Campbell DJ Torgerson RE Thomas JD McClure DM Reid 1998 Direct disclosure of bone density results to patients: effect on knowledge of osteoporosis risk and anxiety level Osteoporos Int 8 584 590 10326065 10.1007/s001980050103 1:STN:280:DyaK1M3lsl2itw%3D%3D (Pubitemid 28566975)
30. JL Stock CE Waud JA Coderre, et al. 1998 Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial Ann Intern Med 128 996 999 9625686 1:STN:280:DyaK1c3ntlygtA%3D%3D (Pubitemid 28275176)
31. Nielsen D, Ryg J, Nielsen W, Knold B, Nissen N, Brixen K (2010) Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns (in press)
32. R Horne J Weinman 1999 Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness J Psychosom Res 47 555 567 10661603 10.1016/S0022-3999(99)00057-4 1:STN:280: DC%2BD3c7isFantw%3D%3D (Pubitemid 30029305)
33. E Lau A Papaioannou L Dolovich, et al. 2008 Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women Can Fam Physician 54 394 402 18337534 (Pubitemid 351413664)
34. JA Switzer S Jaglal ER Bogoch 2009 Overcoming barriers to osteoporosis care in vulnerable elderly patients with hip fractures J Orthop Trauma 23 454 459 19550234 10.1097/BOT.0b013e31815e92d2
35. Tosteson AN, Do TP, Wade SW, Anthony MS, Downs RW (2010) Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US. Osteoporos Int (in press)
36. AH Warriner JR Curtis 2009 Adherence to osteoporosis treatments: room for improvement Curr Opin Rheumatol 21 356 362 19412103 10.1097/BOR. 0b013e32832c6aa4 1:CAS:528:DC%2BD1MXms1yjtr8%3D
37. KF Huybrechts KJ Ishak JJ Caro 2006 Assessment of compliance with osteoporosis treatment and its consequences in a managed care population Bone 38 922 928 16330270 10.1016/j.bone.2005.10.022 (Pubitemid 44498580)